StonvexLoading…
StonvexStonvexStonvexCore line items from BHM's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $68.14M | $48.58M | $41.00M | $32.86M |
Operating Income | $-30.97M | $-12.09M | $-15.90M | $-9.95M |
Net Income | $-32.60M | $-12.09M | $-15.77M | $-1.00M |
EPS (Diluted) | $-3.02 | $-1.10 | $-1.30 | $-0.26 |
Total Assets | $1.15B | $966.99M | $671.62M | $658.89M |
Total Liabilities | $462.56M | $398.10M | $192.75M | $166.91M |
Cash & Equivalents | $169.56M | $115.21M | $80.16M | $78.43M |
Free Cash Flow OCF − CapEx | $10.40M | $-253.00K | $4.35M | $-15.15M |
Shares Outstanding | 3.89M | 3.86M | 3.85M | 3.84M |